Search results for "Stomatitis"

showing 10 items of 136 documents

Constrained evolvability of interferon suppression in an RNA virus.

2016

AbstractInnate immunity responses controlled by interferon (IFN) are believed to constitute a major selective pressure shaping viral evolution. Viruses encode a variety of IFN suppressors, but these are often multifunctional proteins that also play essential roles in other steps of the viral infection cycle, possibly limiting their evolvability. Here, we experimentally evolved a vesicular stomatitis virus (VSV) mutant carrying a defect in the matrix protein (M∆51) that abolishes IFN suppression and that has been previously used in the context of oncolytic virotherapy. Serial transfers of this virus in normal, IFN-secreting cells led to a modest recovery of IFN blocking capacity and to weak …

0301 basic medicineviruses030106 microbiologyAdaptation BiologicalBiologyVirus ReplicationModels BiologicalVirusArticleCell Line03 medical and health sciencesViral ProteinsRNA Virus InfectionsInterferonmedicineHumansRNA VirusesPhosphorylationMultidisciplinaryViral matrix proteinInterferon SuppressionGenetic Variationbiology.organism_classificationVirologyBiological EvolutionImmunity InnateOncolytic virus030104 developmental biologyViral replicationVesicular stomatitis virusViral evolutionMutationInterferonsmedicine.drugScientific reports
researchProduct

Experimental virus evolution in cancer cell monolayers, spheroids, and tissue explants

2021

Viral laboratory evolution has been used for different applications, such as modeling viral emergence, drug-resistance prediction, and therapeutic virus optimization. However, these studies have been mainly performed in cell monolayers, a highly simplified environment, raising concerns about their applicability and relevance. To address this, we compared the evolution of a model virus in monolayers, spheroids, and tissue explants. We performed this analysis in the context of cancer virotherapy by performing serial transfers of an oncolytic vesicular stomatitis virus (VSV-Δ51) in 4T1 mouse mammary tumor cells. We found that VSV-Δ51 gained fitness in each of these three culture systems, and t…

0303 health sciencesOncolytic virusAcademicSubjects/SCI01130AcademicSubjects/SCI02285SpheroidContext (language use)Biologybiology.organism_classificationMicrobiologyVirusCell biologyOncolytic virus03 medical and health sciences0302 clinical medicineExperimental evolutionVesicular stomatitis virus030220 oncology & carcinogenesisVirologyViral evolutionVesicular stomatitis virusCancer cellAcademicSubjects/MED00860VirotherapyResearch Article030304 developmental biology
researchProduct

Denture-related oral mucosal lesions among farmers in a semi-arid Northeastern region of Brazil

2010

Objectives: The purpose of this study was to evaluate the prevalence of denture-related oral mucosal lesions (DML) in São Francisco sertão microregion, in Sergipe State, Northeastern Brazil. Study Design: Data related to gender, age, type of denture, length of denture use, hygiene care, nocturnal denture wear, symptoms, and presence of DML were obtained. Statistical analysis included the Pearson's chi-square and multivariate logistic regression. Results: The global prevalence of DML was 50%, with a significant association between the DML and female gender, age ? 40 years, and length of use ? 5 years. By using the interaction model of logistic regression it was observed that females over 40 …

AdultMaleAdolescentClimateDentistryLogistic regressionYoung AdultPrevalenceHumansMedicineStatistical analysisGeneral DentistryStomatitisDenturesAgedAged 80 and overbusiness.industryMouth MucosaDenture WearOral mucosal lesionsMiddle Aged:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseAgricultural Workers' DiseasesFibrous hyperplasiaOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASFemaleSurgeryHygiene careMouth DiseasesbusinessBrazil
researchProduct

Influence of oral health on mucositis in patients undergoing hematopoietic progenitor cell transplantation (HPCT).

2010

Aims: To establish whether or not the state of patient oral health can influence the occurrence and/or severity of oral mucositis during hematopoietic progenitor cell transplantation (HPCT). Materials and Methods: The study included 72 patients awaiting HPCT. Prior to transplantation, clinical exploration and radiology were carried out and oral photographs were taken. This evaluated the extent of caries present, the number of missing teeth and the number of dental fillings in each patient; CAO (Caries and Obturations Index) DMFS (Decayed, Missing, and Filled Surfaces) and Restoration Indices were calculated. Gingival pathology was also examined by means of the Ainamo and Bay Gingival Bleedi…

AdultMaleAdolescentmedicine.medical_treatmentDentistryOral HealthHematopoietic stem cell transplantationOral healthOral hygieneSeverity of Illness IndexYoung AdultSeverity of illnessmedicineMucositisHumansYoung adultChildGeneral DentistryStomatitisAgedStomatitisbusiness.industryHematopoietic Stem Cell TransplantationMiddle Agedmedicine.disease:CIENCIAS MÉDICAS [UNESCO]Transplantationstomatognathic diseasesOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASSurgeryFemaleResearch-ArticleOdontostomatology for the Disabled or Special PatientsbusinessMedicina oral, patologia oral y cirugia bucal
researchProduct

Phase I Pharmacokinetic/Pharmacodynamic Study of MLN8237, an Investigational, Oral, Selective Aurora A Kinase Inhibitor, in Patients with Advanced So…

2012

Abstract Purpose: Aurora A kinase (AAK) is a key regulator of mitosis and a target for anticancer drug development. This phase I study investigated the safety, pharmacokinetics, and pharmacodynamics of MLN8237 (alisertib), an investigational, oral, selective AAK inhibitor, in 59 adults with advanced solid tumors. Experimental Design: Patients received MLN8237 once daily or twice daily for 7, 14, or 21 consecutive days, followed by 14 days recovery, in 21-, 28-, or 35-day cycles. Dose-limiting toxicities (DLT) and the maximum-tolerated dose (MTD) for the 7- and 21-day schedules were determined. Pharmacokinetic parameters were derived from plasma concentration–time profiles. AAK inhibition in…

AdultMaleCancer ResearchNeutropeniaMaximum Tolerated DoseBiopsyAurora A kinaseAntineoplastic AgentsProtein Serine-Threonine KinasesPharmacologyNeutropeniachemistry.chemical_compoundPharmacokineticsAurora KinasesNeoplasmsBiopsyHumansMedicineStomatitisAgedNeoplasm StagingStomatitismedicine.diagnostic_testbusiness.industryCancerAzepinesMiddle Agedmedicine.diseasePyrimidinesOncologychemistryPharmacodynamicsAlisertibFemalebusinessClinical Cancer Research
researchProduct

Methotrexate, Vinblastine, Epidoxorubicin, and Bleomycin as Second-Line Chemotherapy for Recurrent and/or Metastatic Squamous Cell Carcinoma of the H…

1994

Thirty evaluable patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck region previously treated with cisplatin-based chemotherapy were treated with a combination of methotrexate, vinblastine, epidoxorubicin, and bleomycin as second-line chemotherapy. Besides surgery and/or radiotherapy all patients had previously received chemotherapy as induction therapy or as palliation for recurrent disease. Only 20% of patients achieved a partial objective response with a mean duration of 5.6 months (range 3.2-6.2), and 30% of patients had a stabilization of disease with a mean duration of 4.2+ months (range 3.8-6.0). Patients who responded had rhinopharyngeal carcinoma…

AdultMaleOncologymedicine.medical_specialtyVomitingmedicine.medical_treatmentVinblastineBleomycinSecond line chemotherapyMetastasisBleomycinchemistry.chemical_compoundInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansBasal cellHead and neckAgedEpirubicinCisplatinStomatitisChemotherapybusiness.industryPalliative CareRemission InductionHead and neck cancerLeukopeniaMiddle Agedmedicine.diseaseCombined Modality TherapySurvival RateMethotrexateOtorhinolaryngologychemistryHead and Neck NeoplasmsCarcinoma Squamous CellFemaleFluorouracilCisplatinNeoplasm Recurrence Localbusinessmedicine.drugORL
researchProduct

Oral postinflammatory pigmentation : an analysis of 7 cases

2010

Oral postinflammatory pigmentation (OPP) is a discoloration of the oral mucosa caused by an excess of melanin production and deposition within the basal layer of the epithelium and connective tissue of areas affected by chronic inflammation. Therefore, it is mandatory to demonstrate the association with a previous or concomitant inflammatory process in the same area of oral mucosa. Clinically OPP appears as a localized or diffuse, black to brown pigmentation. OPP may persist for many years even though the disappearing of the pigmentation after the resolution of the inflammatory state has been reported. We reviewed retrospectively the medical records and, when performed, biopsy examinations …

AdultMalePathologymedicine.medical_specialtyConnective tissueMelaninBasal (phylogenetics)BiopsymedicineHumansOral mucosaGeneral DentistryAgedRetrospective StudiesHypopigmentationStomatitisHigh prevalencemedicine.diagnostic_testbusiness.industryMouth MucosaMiddle Agedmedicine.disease:CIENCIAS MÉDICAS [UNESCO]stomatognathic diseasesmedicine.anatomical_structureOtorhinolaryngologyConcomitantUNESCO::CIENCIAS MÉDICASFemaleSurgeryOral lichen planusbusiness
researchProduct

Oral diseases: a 14-year experience of a Chilean institution with a systematic review from eight countries.

2017

ABSTRACTBACKGROUNDRetrospective studies to assess the distribution of oral diseases (ODs) are helpful in estimating the prevalence of oral diagnoses in the population, and thus help in preventive and curative services. Prevalence and frequency data for ODs are available from many countries, but information from Chile is scarce.METHODSThis study investigated the frequency of ODs in a Chilean population. For this, we included all patients treated at the University of Talca (UTALCA, Chile) between 2001 and 2014. Patient characteristics were retrieved from medical files. To contextualize our results, we conducted a systematic review (SystRev) using Publish or Perish software (PoP), Google Schol…

AdultMaleSalivary gland pathologymedicine.medical_specialtyTime FactorsAdolescentPopulationMEDLINEDentistryRecurrent aphthous stomatitis03 medical and health sciencesYoung Adult0302 clinical medicinestomatognathic systemOral and maxillofacial pathologymedicineHumans030212 general & internal medicineChileChildeducationGeneral DentistryAgedLeukoplakiaAged 80 and overeducation.field_of_studyOral Medicine and Pathologybusiness.industryResearchInfant030206 dentistryMiddle Aged:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseDermatologystomatognathic diseasesOtorhinolaryngologyChild PreschoolUNESCO::CIENCIAS MÉDICASSurgeryFemaleOral lichen planusMouth DiseasesbusinessFissured tongue
researchProduct

Clinical manifestations of Behçet's disease in 137 Italian patients: Results of a multicenter study

2005

Objective. To determine the type and frequency of clinical features of Behcets disease in a population of Italian patients. Methods. We retrospectively v studied 137 Italian patients (76 males and 61 females, age at onset 29.6 +/- 12.2 [mean +/-SD] Years) seen consecutively in nine different referral centers. The duration of follow-up (it study entry was 10.9 +/- 8.2 years. Virtually all patients fulfilled the classification criteria developed by the International Study Group for Behcets disease. The clinical manifestations of the patients were recorded by the attending physicians using specifically designed forms. \ Results. The most frequent manifestations at disease onset were oral (78.3…

AdultMaleUveitisStomatitisItalyBehcet Syndromesigns and symptomHumansStomatitis AphthousFemaleAphthousAdult; Behcet Syndrome; Female; Humans; Italy; Male; Retrospective Studies; Stomatitis Aphthous; UveitisRetrospective Studies
researchProduct

Efficacy of a Spray Compound Containing a Pool of Collagen Precursor Synthetic Amino Acids (L-Proline, L-Leucine, L-Lysine and Glycine) Combined with…

2010

Oral mucositis (OM) is a very frequent and potentially severe complication experienced by patients receiving chemotherapy and/or radiotherapy, which often leads to significant morbidity and mortality, and decreased quality of life, and is very costly. Despite its severity and prevalence, there is no standard recognised management today. The aim of this open clinical trial is to evaluate the efficacy and compliance of a new spray compound containing sodium hyaluronate (SH) and a pool of collagen precursor amino acids (AAs) combined with sodium hyaluronate (SH) to manage radio/chemotherapy-induced OM. Twenty-seven consecutive patients with OM were treated according to the manufacturer's inst…

AdultMalemedicine.medical_specialtyAdolescentProlineVisual analogue scalemedicine.medical_treatmentImmunologySodium hyaluronateGlycineAntineoplastic AgentsGastroenterologyLesionchemistry.chemical_compoundSettore MED/28 - Malattie OdontostomatologicheLeucineInternal medicinemedicineMucositisHumansImmunology and Allergyhyaluronic acid amino acids oral mucositis oral ulcer spray compound pain wound healingAmino AcidsHyaluronic AcidAdverse effectStomatitisAgedPain MeasurementAged 80 and overPharmacologyStomatitisChemotherapyRadiotherapybusiness.industryLysineMiddle Agedmedicine.diseaseSurgeryClinical trialchemistryHead and Neck NeoplasmsFemaleCollagenmedicine.symptombusinessInternational Journal of Immunopathology and Pharmacology
researchProduct